Last updated: June 24, 2024
Sponsor: Sohag University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Allergies & Asthma
Asthma
Treatment
CBC, CRP ,ESR, ABG , interleukin 6, tumor necrotic factor alpha
Clinical Study ID
NCT06472596
soh-Med-24-05-11MS
Ages 2-18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- all children diagnosed as bronchial asthma at sohag university hospitals from age of 2 years to age of 18 years and donot have any associated disease
Exclusion
Exclusion Criteria:
- persons who have any chronic illness persons who have any associated disease withbronchial asthma persons who missing clinical and laboratory investigations personswho refusing to give written informed consent for the study
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: CBC, CRP ,ESR, ABG , interleukin 6, tumor necrotic factor alpha
Phase:
Study Start date:
June 01, 2024
Estimated Completion Date:
July 11, 2025
Connect with a study center
Marihan Nazmy Shehata
Sohag,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.